• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Innate sensing of cancer's non-immunologic hallmarks.先天感知癌症的非免疫特征。
Curr Opin Immunol. 2018 Feb;50:1-8. doi: 10.1016/j.coi.2017.09.005. Epub 2017 Oct 12.
2
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy.癌症治疗疗效背后的免疫学机制。
Cancer Immunol Res. 2016 Nov;4(11):895-902. doi: 10.1158/2326-6066.CIR-16-0197.
3
Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.核酸传感机制:针对癌症治疗的先天免疫系统
Recent Pat Anticancer Drug Discov. 2018;13(1):2-17. doi: 10.2174/1574892812666171030163804.
4
Editorial overview: Tumour immunology: Are we on the path to win the battle against cancer through immunotherapy?编辑概述:肿瘤免疫学:我们正走在通过免疫疗法战胜癌症的道路上吗?
Curr Opin Immunol. 2018 Apr;51:vii-ix. doi: 10.1016/j.coi.2018.04.018.
5
Innate immune sensing of nucleic acids from pathogens.对病原体核酸的天然免疫感应。
Microbes Infect. 2014 Dec;16(12):977-8. doi: 10.1016/j.micinf.2014.10.003. Epub 2014 Oct 15.
6
A Believer's Overview of Cancer Immunosurveillance and Immunotherapy.癌症免疫监视与免疫治疗的信徒概览。
J Immunol. 2018 Jan 15;200(2):385-391. doi: 10.4049/jimmunol.1701302.
7
Innate immune recognition of cancer.先天性免疫识别癌症。
Annu Rev Immunol. 2015;33:445-74. doi: 10.1146/annurev-immunol-032414-112043. Epub 2015 Jan 22.
8
Metabolic Reprogramming of Immune Cells in Cancer Progression.肿瘤进展中免疫细胞的代谢重编程。
Immunity. 2015 Sep 15;43(3):435-49. doi: 10.1016/j.immuni.2015.09.001.
9
The molecular biology of cancer. Part 2--Why cancers can outsmart our immune systems!癌症的分子生物学。第2部分——癌症为何能智胜我们的免疫系统!
J N J Dent Assoc. 2011 Spring;82(2):34-6.
10
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.抗肿瘤免疫应答中的效应器、记忆和功能失调的 CD8(+) T 细胞命运。
J Immunol Res. 2016;2016:8941260. doi: 10.1155/2016/8941260. Epub 2016 May 22.

引用本文的文献

1
STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity.肿瘤穿透性 PEG-脂质纳米盘递送 STING 激动剂可引发强大的抗癌免疫。
Nat Mater. 2022 Jun;21(6):710-720. doi: 10.1038/s41563-022-01251-z. Epub 2022 May 23.
2
O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers.O-糖基化在慢性淋巴细胞白血病和其他血液癌症中的作用。
Front Immunol. 2021 Nov 18;12:772304. doi: 10.3389/fimmu.2021.772304. eCollection 2021.
3
Deep Learning in Cancer Diagnosis and Prognosis Prediction: A Minireview on Challenges, Recent Trends, and Future Directions.深度学习在癌症诊断和预后预测中的应用:挑战、最新趋势和未来方向的简述。
Comput Math Methods Med. 2021 Oct 31;2021:9025470. doi: 10.1155/2021/9025470. eCollection 2021.
4
Evaluation of IL-17D in Host Immunity to Group A Infection.评价白介素-17D 在 A 群链球菌感染宿主免疫中的作用。
J Immunol. 2020 Dec 1;205(11):3122-3129. doi: 10.4049/jimmunol.1901482. Epub 2020 Oct 19.

本文引用的文献

1
Mechanisms regulating immune surveillance of cellular stress in cancer.调控癌症中细胞应激免疫监视的机制。
Cell Mol Life Sci. 2018 Jan;75(2):225-240. doi: 10.1007/s00018-017-2597-7. Epub 2017 Jul 25.
2
The KEAP1-NRF2 System in Cancer.癌症中的KEAP1-NRF2系统
Front Oncol. 2017 May 4;7:85. doi: 10.3389/fonc.2017.00085. eCollection 2017.
3
Mechanism and Regulation of NLRP3 Inflammasome Activation.NLRP3炎性小体激活的机制与调控
Trends Biochem Sci. 2016 Dec;41(12):1012-1021. doi: 10.1016/j.tibs.2016.09.002. Epub 2016 Sep 23.
4
Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing.细胞质 DNA 感应的 cGAS-STING 途径的调控和功能。
Nat Immunol. 2016 Sep 20;17(10):1142-9. doi: 10.1038/ni.3558.
5
Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance.Nrf2诱导IL-17D以介导肿瘤和病毒监测。
Cell Rep. 2016 Aug 30;16(9):2348-58. doi: 10.1016/j.celrep.2016.07.075. Epub 2016 Aug 18.
6
The unfolded protein response in immunity and inflammation.免疫与炎症中的未折叠蛋白反应。
Nat Rev Immunol. 2016 Aug;16(8):469-84. doi: 10.1038/nri.2016.62. Epub 2016 Jun 27.
7
Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors.药物诱导的多倍体刺激了由 NKG2D 和 DNAM-1 受体介导的抗肿瘤 NK 细胞反应。
Oncoimmunology. 2015 Aug 12;5(2):e1074378. doi: 10.1080/2162402X.2015.1074378. eCollection 2016 Feb.
8
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs.癌症疗法通过内源性非编码RNA激活视黄酸诱导基因I样受体途径。
Oncotarget. 2016 May 3;7(18):26496-515. doi: 10.18632/oncotarget.8420.
9
Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2.髓源性抑制细胞的存活与功能受转录因子Nrf2调控。
J Immunol. 2016 Apr 15;196(8):3470-8. doi: 10.4049/jimmunol.1501785. Epub 2016 Mar 2.
10
Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA.细胞内DNA通过激活AIM2炎性小体对STING通路的拮抗作用。
J Immunol. 2016 Apr 1;196(7):3191-8. doi: 10.4049/jimmunol.1502538. Epub 2016 Feb 29.

先天感知癌症的非免疫特征。

Innate sensing of cancer's non-immunologic hallmarks.

机构信息

Department of Pathology, University of California, San Diego, CA 92093, USA.

Department of Pathology, University of California, San Diego, CA 92093, USA.

出版信息

Curr Opin Immunol. 2018 Feb;50:1-8. doi: 10.1016/j.coi.2017.09.005. Epub 2017 Oct 12.

DOI:10.1016/j.coi.2017.09.005
PMID:29032295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5857403/
Abstract

A cancer mass consists of a complex composition of cancer cells, stromal cells, endothelial cells and also immune cells, which can represent more than half of the cellularity of a solid cancer. These immune cells become activated when they sense cancer antigens and stress ligands. Innate immune cells also detect various aspects of cellular stress that characterize a growing tumor mass. These key hallmarks of cellular stress are also detected by the cancer cell itself. In this review, we highlight studies that show that the cancer cell itself could be considered an 'innate cell' that senses and reacts to non-immunologic hallmarks of cancer, including displaced nucleic acids, proteotoxic stress, oxidative stress, and metabolic alterations.

摘要

肿瘤块由复杂的癌细胞、基质细胞、内皮细胞和免疫细胞组成,这些细胞可以占到实体瘤细胞总数的一半以上。当这些免疫细胞感知到肿瘤抗原和应激配体时,它们就会被激活。先天免疫细胞还可以检测到肿瘤生长过程中细胞应激的各个方面。这些细胞应激的关键特征也会被肿瘤细胞自身检测到。在这篇综述中,我们强调了一些研究,这些研究表明,肿瘤细胞本身可以被视为一种“先天细胞”,可以感知和对包括移位核酸、蛋白毒性应激、氧化应激和代谢改变在内的非免疫肿瘤特征做出反应。